New Drug Offers Hope for CPAP-Free Nights for Sleep Apnea - WebMD
WEBMay 30, 2024 · Could there be a new approach – a simple pill – that eases sleep apnea symptoms and replaces more conventional treatments? That’s what researchers at Apnimed hope.
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
WEBJun 21, 2024 · Eli Lilly on Friday reiterated that Zepbound met the main goal of the trial, which was reducing AHI events. Zepbound led to an average of 27.4 fewer AHI events per hour at 52 weeks in people who ...
Study Identifies First Drug Therapy for Sleep Apnea - UC San Diego Health
WEBJun 21, 2024 · Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study demonstrating the potential of tirzepatide, known to manage type 2 diabetes, as the first effective drug therapy for obstructive sleep apnea (OSA), a sleep-related …
FDA Clears First Oral Appliance for Severe Sleep Apnea
WEBDec 19, 2023 · For the first time, the Food and Drug Administration (FDA) cleared oral devices that treat severe obstructive sleep apnea (OSA). These devices offer an alternative to more common sleep apnea treatments, like continuous positive airway pressure (CPAP) therapy and surgery.
Apple Watch's new sleep apnea detection feature offers over …
WEB2 days ago · LOS ANGELES (KABC) -- The American Medical Association estimates that 30 to 40 million Americans have sleep apnea, but most aren't diagnosed. Now, a new update is coming to the health app on Apple ...
Apple Watch sleep apnea detection gets FDA approval
WEB6 days ago · The U.S. Food and Drug Administration Monday published approval for sleep apnea detection on the Apple Watch Series 9, Series 10, and Watch Ultra 2. The green light comes four days ahead of the ...
FDA approves Apple Watch sleep apnea detection tool - CBS News
WEB6 days ago · Updated on: September 16, 2024 / 3:45 PM EDT / CBS News. A week after Apple held an event revealing its new iPhone, Apple Watch and AirPod models, the U.S. Food and Drug Administration has ...
Apnimed Announces Early Completion of Enrollment in Phase 3 …
WEB4 days ago · About Obstructive Sleep Apnea. Obstructive sleep apnea is a serious chronic sleep-related breathing disease where the upper airway repeatedly collapses during sleep, causing intermittent oxygen deprivation. It is caused by two overlapping mechanisms: neuromuscular dysfunction during sleep and predisposing anatomic abnormalities.
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly …
WEBApr 17, 2024 · Sleep Apnea: New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea. The company reported results of clinical trials involving Zepbound,...
Tirzepatide reduced sleep apnea severity by up to nearly two …
WEBApr 17, 2024 · Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity. Tirzepatide achieved a mean apnea-hypopnea index reduction of up to 63% (about 30 fewer events per hour), meeting all primary and key secondary endpoints in two phase 3 clinical trials.
- Some results have been removed